09:29 Oct 18
Zydus Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Zydus Lifesciences Ltd.
86/100 High Financial Strength
Quality47/100 Mid Valuation
Valuation44/100 Technically Neutral
TechnicalSWOT
Strength
12
Weakness
2
Opportunity
0
Threat
1
1.02L
Market Cap (Cr)
23.72
PE Ratio
5.18
Price to Book Ratio
30.56
RSI
19.74 %
Net Profit Margin
Rating Based on 5 Analysts
Buy
40%
Hold
60%
Sell
0%
Hold
Analyst Price Target
The average price target is 1183.6 with a high estimate of 1439 and low estimate of 710
Current 1018.00
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
